JPMorgan Chase & Co. news

   Watch this stock
Showing stories 1 - 10 of about 164   

Articles published

JPM 68.56 -0.48 (-0.70%)
price chart
Is JPMorgan Chase & Co. Justified In Upgrading United States Steel Corporation?
In a report released on Thursday, JPMorgan Chase & Co. (NYSE:JPM) upgraded United States Steel Corporation (NYSE:X) stock from Neutral to Overweight.
United States Steel Upgraded to "Overweight" at JPMorgan Chase ...  The Legacy
AK Steel Holding Raised to Overweight at JPMorgan Chase & Co. (AKS)  Dakota Financial News
Shares of JP Morgan Chase & Co (NYSE:JPM) Sees Large Inflow of Net Money Flow
J P Morgan Chase & Co (NYSE:JPM) had a weak trading session and its shares were last down at $68.92, down -0.02% or -0.03 points.
Recent Investment Analysts' Ratings Updates for JPMorgan Chase & Co ...  Dakota Financial News
JPMorgan Chase & Co. Rating Reiterated by Deutsche Bank (JPM)  sleekmoney
JPMorgan Chase & Co. (JPM) Stock: Deutsche Bank Rates A Buy
JP Morgan Chase & Co. stock headed towards the positive territory in the pre-market trading hours today after Deutsche Bank's Markets Research updated the stock.
JPMorgan Chase & Co. Given "Buy" Rating at Deutsche Bank (JPM)  Dakota Financial News
J P Morgan Chase & Co (NYSE:JPM) Short Interest Update  Money Flow Index
Schroders plc's Overweight Rating Reiterated at JPMorgan Chase & Co. (SDR)
Schroders plc logo Schroders plc (LON:SDR)'s stock had its “overweight” rating restated by JPMorgan Chase & Co.
St. James's Place plc Rating Reiterated by JPMorgan Chase & Co. (STJ)  The Legacy
JPMorgan Chase & Co. Raises Ferrexpo Plc Price Target to GBX 70 (FXPO)  WKRB News
Active Stocks Investor's Alert: Pfizer Inc. (NYSE:PFE), JPMorgan Chase & Co ...
Pfizer stated financial results for second-quarter 2015 and declared enhances to the midpoints of its 2015 financial guidance(3) ranges for stated revenues(1) and stated(1) and adjusted(2) diluted EPS.
Acorda Therapeutics's Neutral Rating Reiterated at JPMorgan Chase & Co. (ACOR)
Acorda Therapeutics logo Acorda Therapeutics (NASDAQ:ACOR)'s stock had its “neutral” rating restated by analysts at JPMorgan Chase & Co. in a note issued to investors on Friday, Marketbeat.com reports. They presently have a $42.00 price objective on ...
Amgen Given Neutral Rating at JPMorgan Chase & Co. (AMGN)
Amgen logo Amgen (NASDAQ:AMGN)'s stock had its “neutral” rating reaffirmed by JPMorgan Chase & Co. in a note issued to investors on Friday, MarketBeat reports.
Southwest Airlines Upgraded to Overweight by JPMorgan Chase & Co. (LUV)
Southwest Airlines Co logo JPMorgan Chase & Co. upgraded shares of Southwest Airlines (NYSE:LUV) from a neutral rating to an overweight rating in a research report sent to investors on Thursday, TheFlyOnTheWall.
Southwest Airlines Raised to Overweight at JPMorgan Chase & Co. (LUV)  Dakota Financial News
JPMorgan Chase & Co. Reaffirms Overweight Rating for American Airlines Group (AAL)
American Airlines Group logo American Airlines Group (NASDAQ:AAL)'s stock had its “overweight” rating reissued by stock analysts at JPMorgan Chase & Co. in a note issued to investors on Thursday, MarketBeat.com reports. They currently have a $72.00 ...
American Airlines Group Given Overweight Rating at JPMorgan Chase & Co ...  Mideast Time
United Continental Holdings Earns "Overweight" Rating from JPMorgan Chase & Co ...
United Continental Holdings logo United Continental Holdings (NYSE:UAL)'s stock had its “overweight” rating restated by investment analysts at JPMorgan Chase & Co. in a research note issued to investors on Thursday, MarketBeat reports. They presently ...
United Continental Holdings Receives "Overweight" Rating from ...  The Legacy